Clinical Trial Update: First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

First-in-human investigation of JMT108 Injection in participants with advanced cancers, spanning Phase 1 and Phase 2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• JMT108

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Advanced Malignant Tumors | Phase 1, Phase 2 | Status: RECRUITING